• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

造血干细胞中微小RNA-155的持续表达会引发骨髓增殖性疾病。

Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder.

作者信息

O'Connell Ryan M, Rao Dinesh S, Chaudhuri Aadel A, Boldin Mark P, Taganov Konstantin D, Nicoll John, Paquette Ronald L, Baltimore David

机构信息

Department of Biology, California Institute of Technology, Pasadena, CA 91125, USA.

出版信息

J Exp Med. 2008 Mar 17;205(3):585-94. doi: 10.1084/jem.20072108. Epub 2008 Feb 25.

DOI:10.1084/jem.20072108
PMID:18299402
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2275382/
Abstract

Mammalian microRNAs are emerging as key regulators of the development and function of the immune system. Here, we report a strong but transient induction of miR-155 in mouse bone marrow after injection of bacterial lipopolysaccharide (LPS) correlated with granulocyte/monocyte (GM) expansion. Demonstrating the sufficiency of miR-155 to drive GM expansion, enforced expression in mouse bone marrow cells caused GM proliferation in a manner reminiscent of LPS treatment. However, the miR-155-induced GM populations displayed pathological features characteristic of myeloid neoplasia. Of possible relevance to human disease, miR-155 was found to be overexpressed in the bone marrow of patients with certain subtypes of acute myeloid leukemia (AML). Furthermore, miR-155 repressed a subset of genes implicated in hematopoietic development and disease. These data implicate miR-155 as a contributor to physiological GM expansion during inflammation and to certain pathological features associated with AML, emphasizing the importance of proper miR-155 regulation in developing myeloid cells during times of inflammatory stress.

摘要

哺乳动物的微小RNA正逐渐成为免疫系统发育和功能的关键调节因子。在此,我们报道,注射细菌脂多糖(LPS)后,小鼠骨髓中miR-155会出现强烈但短暂的诱导,这与粒细胞/单核细胞(GM)扩增相关。通过证明miR-155足以驱动GM扩增,在小鼠骨髓细胞中强制表达会导致GM增殖,其方式类似于LPS处理。然而,miR-155诱导的GM群体表现出髓系肿瘤的病理特征。与人类疾病可能相关的是,发现miR-155在某些亚型急性髓系白血病(AML)患者的骨髓中过表达。此外,miR-155抑制了一部分与造血发育和疾病相关的基因。这些数据表明,miR-155在炎症期间对生理性GM扩增以及与AML相关的某些病理特征有作用,强调了在炎症应激期间对发育中的髓系细胞进行适当miR-155调节的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d3a/2275382/fd8bc5ff0c49/jem2050585f07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d3a/2275382/c506bae432c5/jem2050585f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d3a/2275382/c009171083d5/jem2050585f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d3a/2275382/495f0d8bdda5/jem2050585f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d3a/2275382/fd8bc5ff0c49/jem2050585f07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d3a/2275382/c506bae432c5/jem2050585f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d3a/2275382/c009171083d5/jem2050585f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d3a/2275382/495f0d8bdda5/jem2050585f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d3a/2275382/fd8bc5ff0c49/jem2050585f07.jpg

相似文献

1
Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder.造血干细胞中微小RNA-155的持续表达会引发骨髓增殖性疾病。
J Exp Med. 2008 Mar 17;205(3):585-94. doi: 10.1084/jem.20072108. Epub 2008 Feb 25.
2
Leukemogenic Ptpn11 causes fatal myeloproliferative disorder via cell-autonomous effects on multiple stages of hematopoiesis.致白血病的Ptpn11通过对造血多个阶段的细胞自主效应导致致命的骨髓增殖性疾病。
Blood. 2009 Apr 30;113(18):4414-24. doi: 10.1182/blood-2008-10-182626. Epub 2009 Jan 29.
3
MicroRNA-143 targets ERK5 in granulopoiesis and predicts outcome of patients with acute myeloid leukemia.微小 RNA-143 靶向调控粒细胞生成中的 ERK5 并预测急性髓系白血病患者的预后。
Cell Death Dis. 2018 Jul 26;9(8):814. doi: 10.1038/s41419-018-0837-x.
4
MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1.微小RNA-9通过下调Hes1促进核型正常的成人CD34阳性急性髓细胞白血病中白血病细胞的增殖。
Tumour Biol. 2016 Jun;37(6):7461-71. doi: 10.1007/s13277-015-4581-x. Epub 2015 Dec 17.
5
microRNA-29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development, and acute myeloid leukemia.miRNA-29a 诱导造血祖细胞出现异常自我更新能力,偏向髓系发育,并导致急性髓系白血病。
J Exp Med. 2010 Mar 15;207(3):475-89. doi: 10.1084/jem.20090831. Epub 2010 Mar 8.
6
miR-155 promotes FLT3-ITD-induced myeloproliferative disease through inhibition of the interferon response.微小RNA-155通过抑制干扰素反应促进FLT3-ITD诱导的骨髓增殖性疾病。
Blood. 2017 Jun 8;129(23):3074-3086. doi: 10.1182/blood-2016-09-740209. Epub 2017 Apr 21.
7
MiR-181 family: regulators of myeloid differentiation and acute myeloid leukemia as well as potential therapeutic targets.微小RNA-181家族:髓系分化和急性髓系白血病的调节因子以及潜在的治疗靶点。
Oncogene. 2015 Jun;34(25):3226-39. doi: 10.1038/onc.2014.274. Epub 2014 Sep 1.
8
Complete miRNA-15/16 loss in mice promotes hematopoietic progenitor expansion and a myeloid-biased hyperproliferative state.在小鼠中完全缺失 miRNA-15/16 可促进造血祖细胞的扩增和偏嗜性髓系的过度增殖状态。
Proc Natl Acad Sci U S A. 2023 Oct 24;120(43):e2308658120. doi: 10.1073/pnas.2308658120. Epub 2023 Oct 16.
9
The PU.1-Modulated MicroRNA-22 Is a Regulator of Monocyte/Macrophage Differentiation and Acute Myeloid Leukemia.PU.1 调控的微小RNA-22 是单核细胞/巨噬细胞分化及急性髓系白血病的调节因子。
PLoS Genet. 2016 Sep 12;12(9):e1006259. doi: 10.1371/journal.pgen.1006259. eCollection 2016 Sep.
10
Knock-in of an internal tandem duplication mutation into murine FLT3 confers myeloproliferative disease in a mouse model.将内部串联重复突变敲入小鼠FLT3基因,在小鼠模型中引发骨髓增殖性疾病。
Blood. 2008 Apr 1;111(7):3849-58. doi: 10.1182/blood-2007-08-109942. Epub 2008 Feb 1.

引用本文的文献

1
Self-modulating therapeutic platform using engineered miRNA-responsive oligonucleotides.利用工程化微小RNA响应寡核苷酸的自调节治疗平台。
Nano Converg. 2025 Jun 30;12(1):32. doi: 10.1186/s40580-025-00499-w.
2
Advancing protein biosensors: redefining detection through innovations in materials, mechanisms, and applications for precision medicine and global diagnostics.推进蛋白质生物传感器:通过材料、机制及精准医学和全球诊断应用方面的创新重新定义检测。
RSC Adv. 2025 Apr 11;15(15):11523-11536. doi: 10.1039/d4ra06791f. eCollection 2025 Apr 9.
3
Circulating MicroRNAs and Cytokines Associated with Celiac Disease.

本文引用的文献

1
MicroRNA targeting specificity in mammals: determinants beyond seed pairing.哺乳动物中微小RNA的靶向特异性:种子配对之外的决定因素。
Mol Cell. 2007 Jul 6;27(1):91-105. doi: 10.1016/j.molcel.2007.06.017.
2
MicroRNAs 17-5p-20a-106a control monocytopoiesis through AML1 targeting and M-CSF receptor upregulation.微小RNA 17-5p-20a-106a通过靶向AML1和上调M-CSF受体来调控单核细胞生成。
Nat Cell Biol. 2007 Jul;9(7):775-87. doi: 10.1038/ncb1613. Epub 2007 Jun 24.
3
MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis.
与乳糜泻相关的循环微小RNA和细胞因子
Middle East J Dig Dis. 2024 Jul;16(3):185-192. doi: 10.34172/mejdd.2024.388. Epub 2024 Jul 31.
4
The AC010247.2/miR-125b-5p axis triggers the malignant progression of acute myelocytic leukemia by IL-6R.AC010247.2/miR-125b-5p轴通过白细胞介素-6受体触发急性髓细胞白血病的恶性进展。
Heliyon. 2024 Sep 10;10(18):e37715. doi: 10.1016/j.heliyon.2024.e37715. eCollection 2024 Sep 30.
5
Exosomal Non-coding RNA Derived from Mesenchymal Stem Cells (MSCs) in Autoimmune Diseases Progression and Therapy; an Updated Review.外泌体非编码 RNA 源自间充质干细胞 (MSCs) 在自身免疫性疾病进展和治疗中的作用:最新综述。
Cell Biochem Biophys. 2024 Dec;82(4):3091-3108. doi: 10.1007/s12013-024-01432-4. Epub 2024 Sep 3.
6
Epigenetic regulation of megakaryopoiesis and platelet formation.巨核细胞生成和血小板形成的表观遗传调控。
Haematologica. 2024 Oct 1;109(10):3125-3137. doi: 10.3324/haematol.2023.284951.
7
miRNA-21, an Important Regulator of Autoimmune Diseases.微小RNA-21,自身免疫性疾病的重要调节因子。
Curr Mol Med. 2025;25(6):697-709. doi: 10.2174/0115665240290075240514164601.
8
Exploring non-coding RNA mechanisms in hepatocellular carcinoma: implications for therapy and prognosis.探讨肝细胞癌中非编码 RNA 机制:对治疗和预后的影响。
Front Immunol. 2024 May 10;15:1400744. doi: 10.3389/fimmu.2024.1400744. eCollection 2024.
9
A Review of Key Regulators of Steady-State and Ineffective Erythropoiesis.稳态和无效红细胞生成关键调节因子综述
J Clin Med. 2024 Apr 27;13(9):2585. doi: 10.3390/jcm13092585.
10
Are Vascular Endothelium and Angiogenesis Effective MicroRNA Biomarkers Associated with the Prediction of Early-Onset Preeclampsia (EOPE) and Adverse Perinatal Outcomes?血管内皮和血管生成是否为与预测早发型子痫前期(EOPE)和不良围生期结局相关的有效 miRNA 生物标志物?
Reprod Sci. 2024 Mar;31(3):803-810. doi: 10.1007/s43032-023-01367-w. Epub 2023 Oct 17.
髓样分化因子88(MyD88)依赖的未成熟GR-1(+)CD11b(+)细胞群扩增在脓毒症中诱导T细胞抑制和Th2极化。
J Exp Med. 2007 Jun 11;204(6):1463-74. doi: 10.1084/jem.20062602. Epub 2007 Jun 4.
4
An evolutionarily conserved mechanism for microRNA-223 expression revealed by microRNA gene profiling.通过微小RNA基因谱分析揭示的微小RNA-223表达的一种进化保守机制。
Cell. 2007 May 4;129(3):617-31. doi: 10.1016/j.cell.2007.02.048.
5
Requirement of bic/microRNA-155 for normal immune function.正常免疫功能对Bic/微小RNA - 155的需求。
Science. 2007 Apr 27;316(5824):608-11. doi: 10.1126/science.1139253.
6
Regulation of the germinal center response by microRNA-155.微小RNA-155对生发中心反应的调控
Science. 2007 Apr 27;316(5824):604-8. doi: 10.1126/science.1141229.
7
miR-181a is an intrinsic modulator of T cell sensitivity and selection.微小RNA-181a是T细胞敏感性和选择的内在调节因子。
Cell. 2007 Apr 6;129(1):147-61. doi: 10.1016/j.cell.2007.03.008. Epub 2007 Mar 22.
8
Dynamic regulation of miRNA expression in ordered stages of cellular development.细胞发育有序阶段中miRNA表达的动态调控。
Genes Dev. 2007 Mar 1;21(5):578-89. doi: 10.1101/gad.1522907.
9
MicroRNA miR-181a correlates with morphological sub-class of acute myeloid leukaemia and the expression of its target genes in global genome-wide analysis.在全基因组分析中,微小RNA miR-181a与急性髓系白血病的形态学亚类及其靶基因的表达相关。
Leukemia. 2007 May;21(5):912-6. doi: 10.1038/sj.leu.2404605. Epub 2007 Mar 1.
10
CD34+ hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control.CD34+造血干祖细胞的微小RNA表达与功能:分化控制的电路图
Proc Natl Acad Sci U S A. 2007 Feb 20;104(8):2750-5. doi: 10.1073/pnas.0610983104. Epub 2007 Feb 9.